Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GHK-Cu adds another layer of concern because FDA has specifically discussed immunogenicity risk for injectable GHK-Cu related to potential aggregation and peptide-related impurities
The combined GLP-1/GIP activation in tirzepatide creates a synergistic effect on appetite and glucose control that exceeds what either receptor alone could produce
General advice: Pricing Breakdown for Tirzepatide Injections Disclaimer: Pricing may vary based on individual response, dosage, program length, and provider recommendations
SutherlandL.EbnerT.BurchellB.1993The expression of UDPglucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs.452(January 1993),295301,0006-2952 104
US$ 24.53
US$ 21.29
US$ 22.27
US$ 20.75
US$ 20.77
US$ 22.80
